HalfLytely and Bisacodyl Drug Interactions
Currently displaying 49 drugs known to have a minor interaction with HalfLytely and Bisacodyl (bisacodyl / polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride).
- 107 major drug interactions
- 298 moderate drug interactions
- 49 minor drug interactions
Minor interactions with HalfLytely and Bisacodyl (bisacodyl / polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride)
Note: Showing generic names only.
A
C
D
E
F
H
I
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
L
M
N
O
P
Q
R
T
V
HalfLytely and Bisacodyl disease interactions
There are 16 disease interactions with HalfLytely and Bisacodyl (bisacodyl / polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- dehydration/diarrhea
- dehydration
- familial periodic paralysis
- hyperkalemia
- renal dysfunction
- GI irritation
- sodium/water imbalance
- acute surgical abdomen
- rectal bleeding
- acid/base balance
- acidosis
- acidosis
More about HalfLytely and Bisacodyl (bisacodyl / polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride)
- HalfLytely and Bisacodyl consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: laxatives
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.